Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000029

Chief Scientific Officer gave up 2,027 shares (to pay taxes)

  • Chief Scientific Officer acquired 6,874 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Car Bruce · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-13 Exercise or conversion : show line 1 in the form +6,874 6,874 D
2020-04-14 Shares withheld for taxes : show line 2 in the form −2,027 $40.64 $82,377 4,847 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-13 Exercise or conversion : show line 3 in the form Performance share units −6,874 13,748 D
Loading xslF345X03/wf-form4_158698234017383.xml…